The South Korea Irritable Bowel Syndrome Treatment Market exhibits a dynamic competitive landscape characterized by innovation, strategic partnerships, and technological integration among key players. The market is projected to grow from USD 56.7 million in 2025 to USD 123.75 million by 2035, registering a CAGR of 8.12% during the forecast period. This growth trajectory reflects the collective...